Premium
Etomidate in electroconvulsive therapy
Author(s) -
O'CARROLL T. M.,
BLOGG C. E.,
HOINVILLE E.A.,
SAVEGE T. M.
Publication year - 1977
Publication title -
anaesthesia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/j.1365-2044.1977.tb10108.x
Subject(s) - etomidate , medicine , anesthesia , electroconvulsive therapy , incidence (geometry) , swallowing , surgery , propofol , physics , electroconvulsive shock , optics
In a group of 31 patients undergoing electroconvulsive therapy, there was no significant difference between the times of return of eyelash reflex, swallowing and respiration following a single induction dose of 0.2 mg/kg of etomidate as compared with an induction dose of 0.036 ml/kg of alphaxalone/alphadalone. The incidence of involuntary movements and increased muscle tone was significantly greater after etomidate than following alphaxalone/alphadalone; but the involuntary movements were never marked. The overall incidence of pain on injection was 15% after etomidate. There was a low incidence of venous sequelae following either drug.